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Edited by Gerrit van MeerAbstract Yeast ATP-binding cassette (ABC) proteins are
implicated in many biological phenomena, often acting at cross-
roads of vital cellular processes. Their functions encompass pep-
tide pheromone secretion, regulation of mitochondrial function,
vacuolar detoxiﬁcation, as well as pleiotropic drug resistance
and stress adaptation. Because yeast harbors several homologues
of mammalian ABC proteins with medical importance, under-
standing their molecular mechanisms, substrate interaction and
three-dimensional structure of yeast ABC proteins might help
identifying new approaches aimed at combating drug resistance
or other ABC-mediated diseases. This review provides a compre-
hensive discussion on the functions of the ABC protein family in
the yeast Saccharomyces cerevisiae.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ATP-binding cassette (ABC) proteins constitute one of the
largest protein superfamilies, with more than 3000 members
operating from bacteria to man [1]. Quite remarkably, most
members of the ABC protein family share a similar molecular
architecture and domain organization. Nevertheless, ABC pro-
teins fulﬁll a stunning variety of functions, ranging from
ATP-driven transmembrane transport of great many diﬀerent
molecules, to the regulation of important cellular processes
(for recent comprehensive reviews see [1,2]). The genome of
the baker’s yeast Saccharomyces cerevisiae harbors 30 distinct
genes encoding ABC proteins, several of which carry out mem-
brane translocation of hundreds of structurally and function-
ally unrelated xenobiotics, mediating cellular detoxiﬁcationAbbreviations: ABC, ATP-binding cassette; PDR, pleiotropic drug
resistance; MDR, multidrug resistance; NBD, nucleotide-binding
domain; TMS, transmembrane-spanning segment; ER, endoplasmatic
reticulum; MRP, multidrug resistance-related protein; CFTR, cystic
ﬁbrosis transmembrane conductance regulator; NTE, N-terminal
extension; LCFA, long chain fatty acid; PDREs, pleiotropic drug
resistance elements
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doi:10.1016/j.febslet.2005.12.050or conferring pleiotropic drug resistance (PDR). These are
generally referred to as ABC drug eﬄux pumps [1].
PDR in yeast is similar to multidrug resistance (MDR) phe-
nomena in tumor cells [2], parasites, fungal pathogens or even
in bacteria [1]. However, ABCproteins not only function as sim-
ple membrane transporters, they are also implicated in mainte-
nance of mitochondrial function, maturation of cytosolic Fe/S
proteins, pheromone secretion, peroxisome biogenesis, stress re-
sponse, as well as lipid bilayer homeostasis and lipid uptake [1].
The domain organization of ABC proteins is deﬁned by the
presence of at least one nucleotide-binding domain (NBD).
NBDs carry a highly conserved ATP-binding motif, as well as
signaturemotifs that are diagnostic hallmarks forABCproteins.
The NBDs are required to fuel membrane transport or other
functions by hydrolysis of ATP. In addition, membrane-bound
ABC proteins usually contain variable numbers of predicted
transmembrane-spanning segments (TMS) that somehowdeter-
mine distinct substrate speciﬁcities of individual ABC proteins.
TMSs are certainly instrumental for the architecture of substrate
translocation pores, but their structure remains elusive. This re-
view shall discuss yeast ABC proteins that have been studied be-
yond simple sequence identiﬁcation, emphasizing the molecular
structure–function properties of those operating in S. cerevisiae.2. The molecular architecture of yeast ABC proteins
ABC proteins in S. cerevisiae were classiﬁed into ﬁve distinct
classes, represented by the PDR, MRP/cystic ﬁbrosis trans-
membrane conductance regulator (CFTR), MDR, ALDp,
and the YEF3/RLI subfamilies [3]. The NBD domains cover
approximately 250 residues, containing ﬁve conserved amino
acid motifs. The most conserved features found in any given
NBD, are the C-loop or ABC signature motif (LSGGQ), as
well as the Walker A and B motifs, which are also present in
all ATP-binding proteins. Moreover, two less conserved re-
gions contain diagnostic hallmark features. The so-called cen-
ter motif is located between Walker A and B, and a second
sequence lies downstream of Walker B [1].
In contrast to the high conservation of NBDs, there is con-
siderable variation in the appearance and arrangements of
TMSs between diﬀerent ABC subfamilies. While the PDR,
MRP/CFTR, MDR and ALDp family members contain at
least six predicted TMSs, YEF3/RLI proteins lack any obvious
TMS (Fig. 1). Full-size ABC proteins have a tandemly dupli-
cated organization, with usually six predicted membrane heli-
ces in each half, arranged either in a forward (TMS6-NBD)2blished by Elsevier B.V. All rights reserved.
Table 1
ABC proteins in the yeast S. cerevisiae
ABC proteins Family Length Topology Function Substrates Reference
Plasma membrane
Pdr5p PDR 1511 (NBD-TMS6)2 PDR, lipid transport Cycloheximide, azoles, mycotoxins [9,57]
Snq2p PDR 1501 (NBD-TMS6)2 PDR Drugs, mutagens [10,60]
Pdr12p PDR 1511 (NBD-TMS6)2 Weak acid stress response Weak organic acids [17]
Pdr15p PDR 1529 (NBD-TMS6)2 Gerneral stress response Drugs, herbicides, 2,4-DCP [18,61]
Aus1p PDR 1394 (NBD-TMS6)2 Sterol uptake Sterols [19]
Pdr11p PDR 1411 (NBD-TMS6)2 Sterol uptake Sterols [19]
Yor1p MRP/CFTR 1477 NTE(TMS6-NBD)2 PDR, lipid transport Oligomycin, phospholipids [21]
Ste6p MDR 1290 (TMS6-NBD)2 Mating factor transport a-factor pheromone [23,24]
Vacuole
Ycf1p MRP/CFTR 1515 NTE(TMS6-R-NBD)2 Cellular detoxiﬁcation GS-conjugates, heavy metals [29]
Bpt1p MRP/CFTR 1559 NTE(TMS6-NBD)2 Cellular detoxiﬁcation Unconj. bilirubin, cadmium, arsenate [37–39]
Ybt1p MRP/CFTR 1661 NTE(TMS6-NBD)2 Unknown Bile acids, taurocholate [40]
Mitochondria
Atm1p MDR 694 TMS6-NBD Fe(S)-translocation Fe(S)-proteins [41,42]
Mdl1p MDR 696 TMS6-NBD Oxidative stress response Peptides [46,47]
Mdl2p MDR 820 TMS6-NBD Unknown Unknown [1]
Peroxisomes
Pxa1p ALDp 870 TMS6-NBD Fatty acid transport LCFA [50,54]
Pxa2p ALDp 853 TMS6-NBD Fatty acid transport LCFA [50,54]
Abbreviations. NBD, nucleotide binding domain; TMS, transmembrane spanning segment; NTE, N-terminal extension; PDR, pleiotropic drug
resistance; PL, phospholipids; GS, glutathione S; LCFA, long chain fatty acid.
Fig. 1. Predicted topology and domain organization of ABC protein subfamilies. The cartoon depicts the predicted membrane topology and domain
organization of all subfamilies encoding yeast ABC proteins (see text for details). NBD, nucleotide-binding domain; NTE, N-terminal extension;
TMS, transmembrane segment.
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CFTR proteins carry an additional TMS at the N-terminus,
known as N-terminal extension (NTE).
A catalytic cycle of yeast ABC proteins as originally pro-
posed for mammalian P-glycoprotein [4] has not been experi-
mentally veriﬁed. Indeed, the transport mechanisms of yeast
ABC transporters or their molecular mode of action has re-
mained obscure.3. Functions of ABC proteins in S. cerevisiae
Yeast cells can quickly counteract toxic environmental chal-
lenges through eﬃcient detoxiﬁcation systems such as the PDR
machinery. PDR originates from overexpression of plasma
membrane pumps as well as vacuolar transporters (Table 1).
It is important to recognize that PDR not only causes hyper-
tolerance to many unrelated exogenous drugs or xenobiotics,
H. Jungwirth, K. Kuchler / FEBS Letters 580 (2006) 1131–1138 1133it also protects cells from unwanted side eﬀects of endogenous
toxic metabolites. This typically involves members of the ma-
jor facilitator superfamily (MFS) [5,6], as well as several
ABC pumps homing in cellular membrane compartments
(Fig. 2). Furthermore, many ABC transporters are tightly reg-
ulated by transcription factors within the so-called PDR net-
work (Fig. 3) that modulates levels of numerous membrane
transporters under physiological as well as adverse conditions
[7].4. Cellular distribution of ABC transporters
4.1. Plasma membrane ABC transporters – the ﬁrst defense line
Except for Adp1p, all PDR members are full-size ABC pro-
teins sharing a duplicated reverse (NBD-TMS6)2 conﬁgurationFig. 2. Membrane localization of yeast ABC proteins. The cartoon depicts th
the cell surface, in the vacuole, as well as in mitochondria and peroxisome
sequencing are depicted (see text for details). N, nucleus; V, vacuole; E
mitochondrion, P, peroxisome.
Fig. 3. The PDR network in yeast. Genes in the centerline represent target g
the cartoon only lists genes of the ABC family. The yeast PDR network also
cases (see text for details). Red lines indicate a negative regulatory impact, w(Fig. 1 and Table 1). Because certain PDR-transporters medi-
ate translocation of anticancer drugs, phospholipids, peptides,
steroids and herbicides, they can be regarded as the ﬁrst line of
defense in S. cerevisiae [8].
The best characterized plasma membrane members of the
PDR-subfamily are the related ABC transporters Pdr5p [9]
and Snq2p [10]. Overexpression of Pdr5p and Snq2p leads to
PDR, since they extrude hundreds of structurally and func-
tionally unrelated xenobiotics across the plasma membrane
[10,11]. Furthermore, Pdr5p levels are high in the logarithmic
growth phase, while levels decrease signiﬁcantly when cells exit
exponential growth. Thus, Pdr5p may operate in detoxiﬁcation
mainly during exponential growth [12], although endogenous
substrates remain undisclosed.
A three-dimensional reconstruction of Pdr5p revealed a di-
meric organisation, in which each monomer protruded frome subcellular localization of prominent membrane ABC transporters at
s. Only ABC transporters whose functions have been studied beyond
R, endoplasmic reticulum, GV, Golgi vesicles; ES, endosomes. M,
enes of transcriptional regulators depicted above and below. Note that
contains non-ABC genes whose function has not established in many
hile black lines ending with an arrow indicate positive regulation.
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close proximity and asymmetrically organized [13]. This is con-
trasting earlier genetic data suggesting that Pdr5p is active as a
monomer [14]. Notably, the shape and structure of Pdr5p
TMS10 and its neighbouring extracellular loop 6, perhaps
through interaction with other TMSs, determines both speci-
ﬁcity and susceptibility to inhibitors [15], as well as proper
transporter folding [16].
The domain structure of Pdr5p appears established, but this
is not true for other PDR family members, including Pdr12p,
Pdr15p and Pdr10p. Notably, Pdr12p does not transport
hydrophobic drugs, but confers resistance to weak organic
acids. Pdr12p, the closest homologue of Snq2p, mediates en-
ergy-dependent extrusion of water-soluble carboxylate anions,
such as those used for food preservation, including benzoate,
sorbate and propionate [17].
The full-sizeABC transporter Pdr15p is another plasmamem-
brane protein whose function is not well understood, although it
confers resistance to chloramphenicol and polyoxyethylene-
9-laurylether [18], as well as herbicides (Mamnun et al., in
preparation). Finally, two additional plasma membrane PDR-
transporters, Aus1p and Pdr11p, may be involved in sterol
uptake when endogenous sterol biosynthesis is impaired, as
for example during anaerobic growth [19]. AUS1 is also upreg-
ulated in response to azole treatment [20], implying that it could
mediate drug eﬄux. Alternatively, Aus1p may somehow coun-
teract aberrant membrane lipid organization as caused by the
absence of ergosterol, a direct consequence of azole treatment.
Although S. cerevisiae harbors several MRP/CFTR mem-
bers, the Yor1p oligomycin transporter appears as the only
one in the plasma membrane. The phenylalanine residue at po-
sition 670 of NBD1 in Yor1p is critical for function; its dele-
tion results in an unstable Yor1p variant retained in the
endoplasmatic reticulum (ER) and unable to confer oligomy-
cin resistance [21]. Moreover, mutagenesis of N-terminal and
C-terminal Yor1p regions suggest that multiple signals drive
proper Yor1p traﬃcking [22]. Finally, the only full-size ABC
protein of the MDR-subfamily, Ste6p, was the ﬁrst ABC trans-
porter identiﬁed in yeast, mediating the export of the farnesy-
lated a-factor lipopeptide pheromone, which is essential for
mating of haploid yeast cells [23–25].4.2. Vacuolar ABC transporters – the intracellular defense line
A major task of yeast MRP/CFTR proteins seems to be vac-
uolar sequestration [7,8] via transport of a variety of toxic
compounds, a function quite similar to the mammalian ortho-
logues operating in liver detoxiﬁcation of conjugated xenobiot-
ics [1]. The yeast cadmium factor (Ycf1p) mediates vacuolar
detoxiﬁcation of heavy metals and glutathione-S conjugates
(GS-conjugates) [26–29], as well as red pigment accumulating
in ade2 mutant cells [30]. Ycf1p is a yeast orthologue of mam-
malian MRPs, which have been implicated in MDR pheno-
types of tumor cells, as well as in prominent genetic defects
in hepatobiliary transport processes [1]. The domain organisa-
tion of Ycf1p also includes a putative regulatory domain (R-
domain) as present in CFTR [31], as well as the NTE present
only in the MRP subfamily [32,33]. The NTE appears neces-
sary for eﬃcient membrane localization of Ycf1p [34]. Phos-
phorylation of two residues, Ser908 and Thr911, within the
putative Ycf1p R-domain is essential for cadmium detoxiﬁca-
tion [35]. Furthermore, a unique region within lumenal loop 6in the ﬁrst transmembrane domain of Ycf1p, designated loop 6
insertion (L6ins), is necessary and suﬃcient for proteolytic
processing, and, in addition, appears to regulate substrate
speciﬁcity [36]. Interestingly, recent studies imply a possible
contribution of Ycf1p in cellular aging processes. Absence of
YCF1 results in a dramatic loss of viability during chronolog-
ical aging. This eﬀect is due to increased apoptosis, indicating
that Ycf1p might play an important role in apoptotic cell death
(Jungwirth et al., unpublished results).
The closest homologue of Ycf1p, Bpt1p [37], also mediates
cadmium detoxiﬁcation, resistance to acetaminophen, ade2 pig-
mentation and catalyzes the transport of glutathione conju-
gates, as well as free glutathione [30,38,39]. Another related
vacuolar ABC transporter, Ybt1p/Bat1p, mediates ATP-depen-
dent bile acid transport. While the normal function of Ybt1p/
Bat1p remains unknown, it is conceivable that Ybt1p/Bat1p
sequesters fungal detergent-like molecules equivalent to bile
acids to prevent breakdown of organelle membranes [40].4.3. Mitochondrial and peroxisomal ABC transporters
Three ABC proteins, Atm1p, Mdl1p and Mdl2p, reside in
the inner mitochondrial membrane. The ABC protein Atm1
[41] performs an essential function in the generation of cyto-
solic but not mitochondrial iron–sulfur (Fe/S) proteins by
exporting Fe/S cluster precursors from mitochondria [42].
Atm1p acts as a homodimer, mutations in the NBD aﬀect di-
mer stability [43], and conserved residues in Walker A and B
motifs are essential for function [44].
The ABC protein Mdl1p forms dimeric and maybe even
homo-oligomeric complexes in the presence of ATP, assem-
bling in a nucleotide-dependent manner with monomeric
F1F0-ATP synthase [45]. Mdl1p exports mitochondrial pep-
tides generated by proteolysis of inner-membrane proteins in
the mitochondrial matrix [46]. Moreover, Mdl1p may also play
a role in the regulation of cellular resistance to oxidative stress
[47]. Notably, Mdl1p is the closest homologue of the mamma-
lian transporter associated with antigen presentation (TAP),
which drives transport of antigenic peptides into the ER lumen
[48]. Interestingly, the second mitochondrial ABC transporter
with high sequence similarity to TAP, Mdl2p, does not aﬀect
peptide transport across the inner membrane and its function
escaped discovery so far.
In S. cerevisiae, two peroxisomal ABC transporters, Pxa1p
(also known as Pat2p, Pal1p, Ssh2p) and Pxa2p (also known
as Pal1p, Pal2p), are members of the ALDp-subfamily [49,50].
Both are half-size transporters of the peroxisomal membrane,
sharing a MDR-like TMS6-NBD membrane topology. Pxa1p/
Pxa2p are yeast orthologues of the human Pmp70 and ALDp-
like peroxisomal transporters associated with the fatal neurode-
generative disease adrenoleukodystrophy [1]. The yeast null
mutants fail to grow on fatty acids such as palmitate or oleate
as the sole carbon source [51–53], implying that Pxa1p and
Pxa2p mediate peroxisomal import of long chain fatty acids
(LCFA) for b-oxidation [49,51,54]. Alternatively, Pax1p/Pax2p
might function as a peroxisomal acyl-CoA ﬂippase [55].5. Regulation of ABC gene expression in S. cerevisiae
The binuclear Zn(II)2Cys6 zinc ﬁnger regulators [56] Pdr1p
[57] and Pdr3p [58] are among the master regulators of the
H. Jungwirth, K. Kuchler / FEBS Letters 580 (2006) 1131–1138 1135PDR network (Table 2) they form homo- and heterodimers
[59] and regulate transcription in the promoter of PDR target
genes through cis-acting elements, known as PDREs (pleiotro-
pic drug resistance elements) [60–62]. Transcription of PDR5,
SNQ2, PDR10 and PDR15, as well as YOR1 (Table 2) is con-
trolled by Pdr1p/Pdr3p and Yrr1p, the latter modulating
expression of both SNQ2 and YOR1 [63,64]. PDR3 and
YRR1 are also autoregulated via PDREs in their own promot-
ers [63–65]. Remarkably, Pdr1p and Pdr3p can positively or
negatively regulate expression of target genes, implying that
additional factors modulate their activity [66,67]. For example,
the Zn(II)2Cys6 regulator Rdr1p, acts as a repressor of PDR5
in a PDRE-dependent manner. Heterodimers of Rdr1p with
Pdr1p or Pdr3p compete with Pdr1p/Pdr3p for binding to
PDREs [68]. The zinc cluster protein Stb5p also acts through
PDREs. Stb5p acts predominantly within a Pdr1p heterodi-
mer, while no interactions occur with Pdr3p or Yrr1p, the lat-
ter is only present as a homodimer [56,69].
Genomic approaches uncovered another zinc ﬁnger regula-
tor, Pdr8p, as involved in the PDR network [70]. Pdr8p medi-
ates resistance to ketoconazole and oligomycin, operating
mainly through Yrr1p and its respective target genes. YRM1
(yeast reveromycin resistance modulator) encodes another
Zn(II)2Cys6 regulator acting as a speciﬁc inhibitor of Yrr1p.
In the absence of Yrr1p, Yrm1p activates the transcription
of most genes regulated by Yrr1p, reﬂecting the high level of
complexity of the regulatory processes controlling drug resis-
tance phenotypes in yeast [71].
Recently, yet another novel zinc ﬁnger regulator, War1p,
was identiﬁed as the main modulator of weak acid stress adap-
tation through transcriptional control of PDR12 [72]. War1p
controls a rather small regulon [73], forms homodimers, is acti-
vated by stress-triggered hyper-phosphorylation (Frohner
et al., in preparation), and decorates a cis-acting weak acid re-
sponse element in the PDR12 promotor [72,73].
Ecm22p and Umc2p are members of the Zn(II)2Cys6 tran-
scription factors involved in regulation of membrane sterol
homeostasis [74,75] through control of ABC transporters.
Based on genome-wide transcriptional proﬁling of a Upc2-1Table 2
Regulators of ABC proteins or ABC genes in the yeast S. cerevisiae
Regulator Cellular function
Zn(II)2Cys6
Pdr1p Regulation of PDR
Pdr3p Regulation of PDR
Yrr1p Regulation of PDR
Rdr1p Negative regulation of PDR5
Stb5p Regulation of PDR, Pdr1p-heterodimer
Pdr8 Regulation of PDR
Yrm1p Speciﬁc inhibitor of Yrr1p
War1p Regulation of weak acid stress response
Ecm22p and Upc2p Regulation of sterol biosynthesis
Cys2His2
Msn2p Regulation of general stress response
b-ZIP
Yap1p Regulation of oxidative stress response
Yap8p Modulation of arsenite resistance
General TF and other
Ngg1p Inhibition of Pdr1p activity
PDR, pleiotropic drug resistance; TF, transcription factor.gain-of-function mutant strain that exhibits aerobic sterol in-
ﬂux, PDR11 and AUS1 were identiﬁed as major determinants
required for uptake of free sterols under conditions of im-
paired ergosterol biosynthesis [19].
The ABC transporter Pdr15p is induced upon various stres-
ses, including heat shock, high osmolarity and weak acid stress
in an Msn2p-dependent manner [18]. The Cys2His2 zinc ﬁnger
protein Msn2p, a master regulator of general stress response
pathway, modulates a large set of genes in response to a vari-
ety of diﬀerent environmental stimuli [76]. Interestingly,
Pdr15p stress induction requires Msn2p [18], but bypasses up-
stream components of the HOG pathway [77], suggesting the
existence of a novel as yet undisclosed HOG signaling branch
converging at the downstream Msn2p regulator [18]. More-
over, Pdr15p levels are strongly elevated in cells undergoing
diauxic shift, while expression of Pdr5p almost completely dis-
appears [12,18]. Thus, Pdr15p and Pdr5p may perform non-
overlapping functions related to detoxiﬁcation in diﬀerent
growth phases or under certain metabolic conditions.
Finally, basic-leucine zipper (b-ZIP) transcription factors
such as Yap1p have also been implicated in ABC gene regula-
tion, although their precise role in PDR or stress response has
not been unraveled so far [78,79]. Yap1p decorates promoters
of SNQ2 and YCF1 to modulate their expression [80,81].
Notably, another member of the b-ZIP family, Yap8p, also
participates in arsenite detoxiﬁcation by regulating Ycf1p
expression [82,83]. Interestingly, recent studies revealed a link
between Yap1p and the aging process, because overexpression
of YAP1 signiﬁcantly improves survival during chronological
aging in yeast cells [84], possibly through Ycf1p expression reg-
ulation (Jungwirth et al., unpublished data).6. The physiological role of ABC proteins in S. cerevisiae
For ABC transporters such as Ste6p, Atmp1p, and Pxa1p/
Pxa2p, the physiological substrates have been identiﬁed
[23–25,42,51]. As for PDR transporters, detoxiﬁcation remains
as one of the most plausible physiological function, since theyABC target genes Reference
PDR5, PDR10, PDR11, PDR15, SNQ2, YOR1 [57]









YCF1, SNQ2, PDR5 [80]
YCF1 [83]
[66,67]
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cytotoxic compounds, as well as potentially toxic metabolites
[85]. Furthermore, Ycf1p and Bpt1p drive vacuolar sequestra-
tion of heavy metals as well as GS-conjugates [26–29,39].
Although yeast is a unicellular organism, vacuolar sequestra-
tion of heavy metal ions, rather than their extrusion, might
be explained by a beneﬁcial eﬀect on immediate neighbouring
cells.
Notably, membrane phospholipids and sphingosine long
chain bases (LCBs) are suspected substrates of yeast ABC
transporters such as Pdr5p [86,87]. Indeed, there is accumulat-
ing evidence for a role of eukaryotic and mammalian ABC
proteins in membrane lipid transport [88]. Like certain mam-
malian ABC transporters [89,90], Pdr5p, Yor1p, Pdr10p,
Aus1p and Pdr10p may translocate at least some membrane
phospholipids or even steroles [19,91]. Hence, at least some
ABC transporters may function in controlling or modulating
membrane lipid homeostasis, regulation of membrane perme-
ability and phospholipid bilayer distribution. ABC pumps
could also remove oxidized or damaged membrane lipids.
Indeed, membrane-damaging agents such as detergents and
lysophospholipids, all of which exert massive membrane
stress, strongly induce Pdr15p levels (Mamnun et al., in
preparation).7. Conclusions and perspectives
In summary, in addition to cellular detoxiﬁcation, other
hypothetical physiological function(s) of ABC pumps might
be a role in the dynamic regulation of the membrane lipid com-
positions or bilayer asymmetry. However, facts are modest at
best, as most studies addressing membrane lipid asymmetry
employed short-chain ﬂuorescent lipids as transport or ‘‘ﬂip-
pase’’ substrates, which may be recognized as ‘‘drugs’’ rather
than natural membrane lipids. Hence, reconstituted in vitro
systems [92], as well as natural lipid substrates [89], will be nec-
essary to unequivocally demonstrate functions for ABC trans-
porters in phospholipid homeostasis. During the past years,
intensive research eﬀorts led to a better understanding of the
molecular mechanisms of members of the ABC protein family.
Nevertheless, the cellular substrates and physiological func-
tions of many eukaryotic ABC pumps remain enigmatic. We
can thus anticipate many exciting discoveries on fungal ABC
transporters, particularly when considering the broad variety
of ABC proteins uncovered in the genomes of other yeasts
and especially in those from fungal pathogens.
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